Bill

Bill > HB4428


MI HB4428

MI HB4428
Health: pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow. Creates new act.


summary

Introduced
05/06/2025
In Committee
05/06/2025
Crossed Over
Passed
Dead

Introduced Session

103rd Legislature

Bill Summary

A bill to prescribe the types of opioid antagonists distributed to certain persons or governmental entities in this state; and to provide for the powers and duties of certain state officers and entities.

AI Summary

This bill establishes guidelines for the distribution of opioid antagonists by Michigan's Department of Health and Human Services, focusing on providing more flexibility in how these life-saving medications are distributed. The bill first defines key terms: an "opioid antagonist" is a federally approved drug used to emergency treat opioid overdoses, and an "opioid-related overdose" is a dangerous medical condition resulting from opioid consumption that may cause severe symptoms like respiratory depression or unconsciousness. When the department distributes opioid antagonists at no cost to individuals or governmental entities to help reduce overdose rates, the bill mandates that recipients can choose the specific formulation, delivery device, administration method, and dosage that best suits their needs. However, this choice is not absolute; if selecting a particular formulation or dosage would potentially compromise federal funding for the department, those choices would be restricted. The bill aims to provide greater local control and flexibility in managing opioid antagonist distribution while maintaining the primary goal of preventing overdose deaths.

Committee Categories

Government Affairs

Sponsors (8)

Last Action

House Regulatory Reform (09:00:00 6/5/2025 Room 519, House Office Building) (on 06/05/2025)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
  • ‐ Regulation of Drug Industry and Pharmacies

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...